Versum Yanks Poison Pill As Chancery Merger Fight Roils
Versum Materials Inc. has terminated a stockholder rights offering that attorneys for a class of shareholders branded as an unfair "poison pill" merger defense prompted by Merck KGaA's unsolicited, $5.8 billion...To view the full article, register now.
Already a subscriber? Click here to view full article